NovoCure Limited (NVCR)
(Delayed Data from NSDQ)
$17.45 USD
-0.39 (-2.19%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $17.47 +0.02 (0.11%) 6:38 PM ET
2-Buy of 5 2
D Value C Growth D Momentum D VGM
Brokerage Reports
NovoCure Limited [NVCR]
Reports for Purchase
Showing records 101 - 120 ( 219 total )
Company: NovoCure Limited
Industry: Medical Services
1Q20 Financials: COVID-19 Disrupts Trials, but Revenues All Right
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
COVID-19 Impact on Coverage Universe: Week of April 20 Update
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
COVID-19 Impact on Coverage Universe: Week of April 13 Update
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
CORRECTED AACR 2020 Titles for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
COVID-19 Impact on Coverage Universe: Week of March 30 Update
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
COVID-19 Impact on Coverage Universe: Week of March 30 Update
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
From Underneath The Rubble Sing a Rebel Song
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
4Q19 Financials; Interim LUNAR Data May Illuminate 2H20
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
Preliminary Q4:19: Slowing GBM Script Growth, but Increasing Rev per Patient
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
Company: NovoCure Limited
Industry: Medical Services
3Q19; Novocure Story Unchanged for Us, Awaiting LUNAR 2H20
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: NovoCure Limited
Industry: Medical Services
Biotechnology - SITC 2019 Abstract Title Preview for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R